CeriBell, Inc.

CBLL ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023
Revenue $89.1M $65.4M $45.2M
Cost of Revenue $10.8M $8.7M $7.1M
Gross Profit $78.3M $56.8M $38.2M
Gross Margin 87.9% 86.7% 84.4%
Operating Expenses
Research & Development $19.1M $13.6M $9.0M
SG&A Expense $44.5M $33.8M $20.3M
Operating Income $-58.4M $-39.7M $-30.0M
Operating Margin -65.6% -60.7% -66.4%
Interest Expense
Pretax Income $-53.4M $-40.5M $-29.5M
Income Tax Expense $0 $0 $11.0K
Net Income $-53.4M $-40.5M $-29.5M
Net Margin -60.0% -61.8% -65.1%
EPS (Basic) $-1.46 $-1.13 $-0.93
EPS (Diluted) $-1.46 $-1.13 $-0.93
Shares Outstanding (Basic) 37.6M 36.5M 35.8M 31.8M
Shares Outstanding (Diluted) 37.6M 36.5M 35.8M 31.8M
Dividends Per Share